Previous 10 | Next 10 |
home / stock / dtcff / dtcff news
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), is a publicly-traded biotechnology company working on engineering the next generation vaccines, Antibody Drug Conjugates, ADC ...
Vancouver, British Columbia--(Newsfile Corp. - November 23, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines is pleased to announce the establishmen...
Vancouver, British Columbia--(Newsfile Corp. - November 9, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on the development of next generation cancer therapeutics and infectious disease vaccines is pl...
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a biotechnology company working on the development of next generation cancer therapeutics and infectious disease vaccines is pl...
Vancouver, British Columbia--(Newsfile Corp. - October 13, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines is pleased to announce strong in vitro ...
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines, is finalizing all required steps in pr...
Vancouver, British Columbia--(Newsfile Corp. - September 29, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology Company working on cancer therapeutics and infectious diseases vaccines, is pleased to announce that it will ...
Vancouver, British Columbia--(Newsfile Corp. - September 20, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines is pleased to announce the development...
Vancouver, British Columbia--(Newsfile Corp. - September 14, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines, is pleased to announce the completion...
Vancouver, British Columbia--(Newsfile Corp. - September 7, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on ADC therapeutics for cancer targeting with its Accum TM technology and cancer vaccine ther...
News, Short Squeeze, Breakout and More Instantly...
Defence Therapeutics Inc Cl A Company Name:
DTCFF Stock Symbol:
OTCMKTS Market:
Defence Therapeutics Inc Cl A Website:
Vancouver, British Columbia--(Newsfile Corp. - July 8, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that it...
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce that De...
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce th...